APAC Exosome Research Products Market - Industry Trends And Forecast To 2030

Description

List of Tables

Asia-Pacific exosome research products market is projected to register a substantial CAGR of 40.3% in the forecast period of 2023 to 2030. The new market report contains data for the historic year 2021, the base year of calculation is 2022 and the forecast period is 2023 to 2030.

Market Segmentation:

Asia-Pacific Exosome Research Products Market, By Product (Instruments, and Consumables), Indication (Cancer and Non-Cancer), Application (Therapeutics and Diagnosis), End Users (Hospitals, Clinical Testing Laboratories, Research Centers, Pharmaceutical and Biotechnology Company, Academic Institutes and Others), Distribution Channel (Third Party Distributors, Online, Direct Tender, and Others), Country (China, Japan, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, New Zealand Vietnam, Taiwan, and Rest of Asia-Pacific) Industry Trends and Forecast to 2030

Market Drivers:

Growing prevalence of cancer, chronic inflammation, autoimmune disease, Lyme disease, and other chronic degenerative diseases

Increasing investments in pharmaceutical R&D and life sciences research

Market Players:

The key market players in Asia-Pacific colorectal cancer diagnostics market are listed below:

Hologic Inc.

Luminex Corporation

Thermo Fisher Scientific

Agilent Technologies, Inc.

Microgentas, Cell Guidance Systems LLC

QIAGEN

FUJIFILM Irvine Scientific(a subsidiary of FUJIFILM Holdings Corporation),

CUSABIO TECHNOLOGY LLC

Norgen Biotek Corp.

Miltenyi Biotec

Novus Biologicals

Beckman Coulter, Inc.

JSR Micro NV

Hitachi, Ltd.

INOVIQ

Audubon Bioscience

1 INTRODUCTION 53

1.1 OBJECTIVES OF THE STUDY 53
1.2 MARKET DEFINITION 53
1.3 OVERVIEW OF THE ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET 53
1.4 LIMITATIONS 55
1.5 MARKETS COVERED 55

2 MARKET SEGMENTATION 58

2.1 MARKETS COVERED 58
2.2 GEOGRAPHICAL SCOPE 59
2.3 YEARS CONSIDERED FOR THE STUDY 60
2.4 CURRENCY AND PRICING 60
2.5 DBMR TRIPOD DATA VALIDATION MODEL 61
2.6 MULTIVARIATE MODELLING 64
2.7 PRODUCT LIFELINE CURVE 65
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 66
2.9 DBMR MARKET POSITION GRID 67
2.10 MARKET APPLICATION COVERAGE GRID 69
2.11 VENDOR SHARE ANALYSIS 70
2.12 SECONDARY SOURCES 71
2.13 ASSUMPTIONS 71

3 EXECUTIVE SUMMARY 72

4 PREMIUM INSIGHTS 74

4.1 PESTEL ANALYSIS 75
4.2 PORTER'S FIVE FORCES MODEL 76
4.3 SUPPLY CHAIN ANALYSIS 77
4.4 VALUE CHAIN ANALYSIS 78
4.5 BUSINESS STRATEGY EXCELLENCE 79
4.6 CASE STUDIES 80
4.7 STRENGTH OF PRODUCT PORTFOLIO 82
4.8 TECHNOLOGICAL TRENDS 84
4.9 PRICING ANALYSIS 85

5 INDUSTRY INSIGHTS 86

6 ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET, REGULATIONS 87

7 MARKET OVERVIEW 89

7.1 DRIVERS 91
- 7.1.1 GROWING PREVALENCE OF CANCER, CHRONIC INFLAMMATION, AUTOIMMUNE DISEASE, LYME DISEASE, AND OTHER CHRONIC DEGENERATIVE DISEASES 91
- 7.1.2 INCREASING INVESTMENTS IN PHARMACEUTICAL R&D AND LIFE SCIENCES RESEARCH 91
- 7.1.3 AVAILABILITY OF VARIOUS EXOSOME ISOLATION AND PURIFICATION TECHNIQUES AND PROGRESSING THERAPEUTIC VALUE OF EXOSOME 92
7.2 RESTRAINTS 93
- 7.2.1 LACK OF GOLD STANDARD PROTOCOLS FOR THE DEVELOPMENT AND PRODUCTION OF EXOSOMES 93
- 7.2.2 THE SHORTAGE OF SKILLED PROFESSIONALS REQUIRED FOR THE ISOLATION OF EXOSOME 93
7.3 OPPORTUNITIES 94
- 7.3.1 RISING DEMAND FOR SPECIALIZED TESTING SERVICES AMONG END USERS. 94
- 7.3.2 INCREASING ADVANCEMENT IN EXOSOME TECHNOLOGY 94
- 7.3.3 STRATEGIC INITIATIVES BY MARKET PLAYERS 95
7.4 CHALLENGES 96
- 7.4.1 SIDE EFFECTS ASSOCIATED WITH EXOSOME RESEARCH PRODUCTS 96
- 7.4.2 LATE APPROVAL ASSOCIATED WITH PRODUCT LAUNCHES 96

8 ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT 97

8.1 OVERVIEW 98
8.2 CONSUMABLES 101
- 8.2.1 KITS AND REAGENTS 102
  - 8.2.1.1 EXOSOME BIOMARKER KITS 103
  - 8.2.1.2 EXOSOME ISOLATION KITS 103
  - 8.2.1.3 EXOSOME PURIFICATION KITS 103
  - 8.2.1.4 EXOSOME QUANTITATIVE KITS 103
  - 8.2.1.5 EXOSOME DETECTION KITS 103
  - 8.2.1.6 OTHERS 103
- 8.2.2 EXOSOME STANDARDS 103
- 8.2.3 EXOSOME ANTIBODIES 103
- 8.2.4 CELL LINES 103
- 8.2.5 IMMUNOPLATES 104
- 8.2.6 IMMUNOBEADS 104
- 8.2.7 BIOFLUIDS 104
- 8.2.8 OTHERS 104
8.3 INSTRUMENTS 104
- 8.3.1 BENCHTOP 105
- 8.3.2 STANDALONE 105

9 ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION 106

9.1 OVERVIEW 107
9.2 CANCER 110
- 9.2.1 LUNG CANCER 111
- 9.2.2 BREAST CANCER 111
- 9.2.3 COLORECTAL CANCER 111
- 9.2.4 PROSTATE CANCER 112
- 9.2.5 OTHER CANCER 112
9.3 NON-CANCER 112
- 9.3.1 CARDIOVASCULAR DISEASE 113
- 9.3.2 NEURODEGENERATIVE DISEASE 113
- 9.3.3 INFECTIOUS DISEASE 113
- 9.3.4 OTHERS 113

10 ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET: BY APPLICATION 114

10.1 OVERVIEW 115
10.2 THERAPEUTICS 118
10.3 CONSUMABLES 119
10.4 INSTRUMENTS 119
10.5 DIAGNOSIS 119
10.6 CONSUMABLES 120
10.7 INSTRUMENTS 120

11 ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET, BY END USER 121

11.1 OVERVIEW 122
11.2 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANY 125
11.3 CONSUMABLES 126
11.4 INSTRUMENTS 126
11.5 RESEARCH CENTRES 126
11.6 CONSUMABLES 127
11.7 INSTRUMENTS 127
11.8 ACADEMIC INSTITUTES 127
11.9 CONSUMABLES 128
11.10 INSTRUMENTS 128
11.11 CLINICAL TESTING LABORATORY 128
11.12 CONSUMABLES 129
11.13 INSTRUMENTS 129
11.14 HOSPITALS 130
11.15 CONSUMABLES 131
11.16 INSTRUMENTS 131
11.17 OTHERS 131

12 ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET, BY DISTRIBUTION CHANNEL 132

12.1 OVERVIEW 133
12.2 THIRD PARTY DISTRIBUTORS 136
12.3 DIRECT SALES 136
12.4 ONLINE 137

13 ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET, BY REGION 138

13.1 ASIA-PACIFIC 139
- 13.1.1 CHINA 149
- 13.1.2 JAPAN 155
- 13.1.3 INDIA 161
- 13.1.4 SOUTH KOREA 167
- 13.1.5 AUSTRALIA 173
- 13.1.6 SINGAPORE 179
- 13.1.7 MALAYSIA 185
- 13.1.8 THAILAND 191
- 13.1.9 INDONESIA 197
- 13.1.10 PHILIPPINES 203
- 13.1.11 NEW ZEALAND 209
- 13.1.12 VIETNAM 215
- 13.1.13 TAIWAN 221
- 13.1.14 REST OF ASIA-PACIFIC 227

14 ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET, COMPANY LANDSCAPE 228

14.1 COMPANY SHARE ANALYSIS: ASIA PACIFIC 228

15 SWOT ANALYSIS 229

16 COMPANY PROFILE 230

16.1 THERMO FISHER SCIENTIFIC INC. 230
- 16.1.1 COMPANY SNAPSHOT 230
- 16.1.2 REVENUE ANALYSIS 230
- 16.1.3 COMPANY SHARE ANALYSIS 231
- 16.1.4 PRODUCT PORTFOLIO 231
- 16.1.5 RECENT DEVELOPMENT 232
16.2 EXODX (ACQUIRED BY BIO-TECHNE) 233
- 16.2.1 COMPANY SNAPSHOT 233
- 16.2.2 REVENUE ANALYSIS 233
- 16.2.3 COMPANY SHARE ANALYSIS 234
- 16.2.4 PRODUCT PORTFOLIO 234
- 16.2.5 RECENT DEVELOPMENT 234
16.3 MILTENYI BIOTEC 235
- 16.3.1 COMPANY SNAPSHOT 235
- 16.3.2 COMPANY SHARE ANALYSIS 235
- 16.3.3 PRODUCT PORTFOLIO 236
- 16.3.4 RECENT DEVELOPMENTS 236
16.4 LUMINEX CORPORATION 237
- 16.4.1 COMPANY SNAPSHOT 237
- 16.4.2 PRODUCT PORTFOLIO 237
- 16.4.3 RECENT DEVELOPMENT 237
16.5 HOLOGIC, INC. 238
- 16.5.1 COMPANY SNAPSHOT 238
- 16.5.2 REVENUE ANALYSIS 238
- 16.5.3 COMPANY SHARE ANALYSIS 239
- 16.5.4 PRODUCT PORTFOLIO 239
- 16.5.5 RECENT DEVELOPMENTS 239
16.6 AETHLON MEDICAL, INC. (2022) 240
- 16.6.1 COMPANY SNAPSHOT 240
- 16.6.2 PRODUCT PORTFOLIO 241
- 16.6.3 RECENT DEVELOPMENTS 241
16.7 AGILENT TECHNOLOGIES, INC. 242
- 16.7.1 COMPANY SNAPSHOT 242
- 16.7.2 REVENUE ANALYSIS 242
- 16.7.3 PRODUCT PORTFOLIO 243
- 16.7.4 RECENT DEVELOPMENT 243
16.8 AMSBI0 244
- 16.8.1 COMPANY SNAPSHOT 244
- 16.8.2 PRODUCT PORTFOLIO 244
- 16.8.3 RECENT DEVELOPMENT 244
16.9 AUDUBON BIOSCIENCE. 245
- 16.9.1 COMPANY SNAPSHOT 245
- 16.9.2 PRODUCT PORTFOLIO 245
- 16.9.3 RECENT DEVELOPMENT 245
16.10 BECKMAN COULTER, INC 246
- 16.10.1 COMPANY SNAPSHOT 246
- 16.10.2 PRODUCT PORTFOLIO 246
- 16.10.3 RECENT DEVELOPMENT 246
16.11 BIOVISION INC. (ACQUIRED BY ABCAM PLC) 247
- 16.11.1 COMPANY SNAPSHOT 247
- 16.11.2 REVENUE ANALYSIS 247
- 16.11.3 COMPANY SHARE ANALYSIS 248
- 16.11.4 PRODUCT PORTFOLIO 248
- 16.11.5 RECENT DEVELOPMENT 248
16.12 CELL GUIDANCE SYSTEMS LLC 249
- 16.12.1 COMPANY SNAPSHOT 249
- 16.12.2 PRODUCT PORTFOLIO 249
- 16.12.3 RECENT DEVELOPMENTS 249
16.13 CREATIVE BIOARRAY 250
- 16.13.1 COMPANY SNAPSHOT 250
- 16.13.2 PRODUCT PORTFOLIO 250
- 16.13.3 RECENT DEVELOPMENT 250
16.14 CUSABIO TECHNOLOGY LLC 251
- 16.14.1 COMPANY SNAPSHOT 251
- 16.14.2 PRODUCT PORTFOLIO 251
- 16.14.3 RECENT DEVELOPMENTS 251
16.15 FUJIFILM IRVINE SCIENTIFIC (A SUBSIDIARY OF FUJIFILM HOLDINGS CORPORATION 252
- 16.15.1 COMPANY SNAPSHOT 252
- 16.15.2 REVENUE ANALYSIS 252
- 16.15.3 PRODUCT PORTFOLIO 253
- 16.15.4 RECENT DEVELOPMENT 253
16.16 HBMLS (ACQUIRED BY LONZA) 254
- 16.16.1 COMPANY SNAPSHOT 254
- 16.16.2 REVENUE ANALYSIS 254
- 16.16.3 PRODUCT PORTFOLIO 255
- 16.16.4 RECENT DEVELOPMENT 255
16.17 HITACHI, LTD. 256
- 16.17.1 COMPANY SNAPSHOT 256
- 16.17.2 REVENUE ANALYSIS 256
- 16.17.3 PRODUCT PORTFOLIO 257
- 16.17.4 RECENT DEVELOPMENT 257
16.18 INOVIQ 258
- 16.18.1 COMPANY SNAPSHOT 258
- 16.18.2 REVENUE ANALYSIS 258
- 16.18.3 PRODUCT PORTFOLIO 259
- 16.18.4 RECENT DEVELOPMENT 259
16.19 JSR MICRO NV 260
- 16.19.1 COMPANY SNAPSHOT 260
- 16.19.2 PRODUCT PORTFOLIO 260
- 16.19.3 RECENT DEVELOPMENT 260
16.20 MICROGENTAS 261
- 16.20.1 COMPANY SNAPSHOT 261
- 16.20.2 PRODUCT PORTFOLIO 261
- 16.20.3 RECENT DEVELOPMENTS 261
16.21 NANOSOMIX 262
- 16.21.1 COMPANY SNAPSHOT 262
- 16.21.2 PRODUCT PORTFOLIO 262
- 16.21.3 RECENT DEVELOPMENT 262
16.22 NEXOSOME-ONCOLOGY 263
- 16.22.1 COMPANY SNAPSHOT 263
- 16.22.2 PRODUCT PORTFOLIO 263
- 16.22.3 RECENT DEVELOPMENTS 263
16.23 NORGEN BIOTEK CORP. 264
- 16.23.1 COMPANY SNAPSHOT 264
- 16.23.2 PRODUCT PORTFOLIO 264
- 16.23.3 RECENT DEVELOPMENTS 264
16.24 NOVUS BIOLOGICALS 265
- 16.24.1 COMPANY SNAPSHOT 265
- 16.24.2 PRODUCT PORTFOLIO 265
- 16.24.3 RECENT DEVELOPMENT 266
16.25 PROTEOGENEX 267
- 16.25.1 COMPANY SNAPSHOT 267
- 16.25.2 PRODUCT PORTFOLIO 267
- 16.25.3 RECENT DEVELOPMENT 267
16.26 QIAGEN 268
- 16.26.1 COMPANY SNAPSHOT 268
- 16.26.2 REVENUE ANALYSIS 268
- 16.26.3 PRODUCT PORTFOLIO 269
- 16.26.4 RECENT DEVELOPMENT 269

16.27 ROOSTERBIO, INC. 270
- 16.27.1 COMPANY SNAPSHOT 270
- 16.27.2 PRODUCT PORTFOLIO 270
- 16.27.3 RECENT DEVELOPMENTS 271
16.28 SYSTEM BIOSCIENCES, LLC. 272
- 16.28.1 COMPANY SNAPSHOT 272
- 16.28.2 PRODUCT PORTFOLIO 272
- 16.28.3 RECENT DEVELOPMENT 272

17 QUESTIONNAIRE 273

18 RELATED REPORTS 276

LIST OF TABLES

TABLE 1 ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET, PRICING ANALYSIS 59
TABLE 2 ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT , 2021-2030 (USD THOUSAND) 74
TABLE 3 ASIA PACIFIC CONSUMABLES IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND) 75
TABLE 4 ASIA PACIFIC CONSUMABLES IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 76
TABLE 5 ASIA PACIFIC KITS AND REAGENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 76
TABLE 6 ASIA PACIFIC INSTRUMENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND) 79
TABLE 7 ASIA PACIFIC INSTRUMENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 79
TABLE 8 ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND) 83
TABLE 9 ASIA PACIFIC CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND) 85
TABLE 10 ASIA PACIFIC CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND) 85
TABLE 11 ASIA PACIFIC NON-CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND) 86
TABLE 12 ASIA PACIFIC NON-CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND) 87
TABLE 13 ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 91
TABLE 14 ASIA PACIFIC THERAPEUTICS IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND) 92
TABLE 15 ASIA PACIFIC THERAPEUTICS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 92
TABLE 16 ASIA PACIFIC DIAGNOSIS IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND) 93
TABLE 17 ASIA PACIFIC DIAGNOSIS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 94
TABLE 18 ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 98
TABLE 19 ASIA PACIFIC PHARMACEUTICAL AND BIOTECHNOLOGY COMPANY IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND) 99
TABLE 20 ASIA PACIFIC PHARMACEUTICAL & BIOTECHNOLOGY COMPANY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER 2021-2030 (USD THOUSAND) 99
TABLE 21 ASIA PACIFIC RESEARCH CENTERS IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND) 100
TABLE 22 ASIA PACIFIC RESEARCH CENTERS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER 2021-2030 (USD THOUSAND) 101
TABLE 23 ASIA PACIFIC ACADEMIC INSTITUTES IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND) 102
TABLE 24 ASIA PACIFIC ACADEMIC INSTITUTES IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER 2021-2030 (USD THOUSAND) 102
TABLE 25 ASIA PACIFIC CLINICAL TESTING LABORATORY IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND) 103
TABLE 26 ASIA PACIFIC CLINICAL TESTING LABORATORY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 103
TABLE 27 ASIA PACIFIC HOSPITALS IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND) 104
TABLE 28 ASIA PACIFIC HOSPITALS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER 2021-2030 (USD THOUSAND) 104
TABLE 29 ASIA PACIFIC OTHERS IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND) 105
TABLE 30 ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 109
TABLE 31 ASIA PACIFIC THIRD PARTY DISTRIBUTORS IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND) 110
TABLE 32 ASIA PACIFIC DIRECT SALES IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND) 111
TABLE 33 ASIA PACIFIC ONLINE IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND) 111
TABLE 34 ASIA-PACIFIC EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND) 117
TABLE 35 ASIA-PACIFIC EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 117
TABLE 36 ASIA-PACIFIC CONSUMABLES IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 118
TABLE 37 ASIA-PACIFIC KITS & REAGENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 118
TABLE 38 ASIA-PACIFIC INSTRUMENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 119
TABLE 39 ASIA-PACIFIC EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND) 119
TABLE 40 ASIA-PACIFIC CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND) 119
TABLE 41 ASIA-PACIFIC NON-CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND) 120
TABLE 42 ASIA-PACIFIC EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 120
TABLE 43 ASIA-PACIFIC THERAPEUTICS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 120
TABLE 44 ASIA-PACIFIC DIAGNOSIS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 120
TABLE 45 ASIA-PACIFIC EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 121
TABLE 46 ASIA-PACIFIC PHARMACEUTICAL & BIOTECHNOLOGY COMPANY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 121
TABLE 47 ASIA-PACIFIC RESEARCH CENTERS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 121
TABLE 48 ASIA-PACIFIC ACADEMIC INSTITUTES IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 122
TABLE 49 ASIA-PACIFIC CLINICAL TESTING LABORATORY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 122
TABLE 50 ASIA-PACIFIC HOSPITALS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 122
TABLE 51 ASIA-PACIFIC EXOSOME RESEARCH PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 122
TABLE 52 CHINA EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 123
TABLE 53 CHINA CONSUMABLES IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 123
TABLE 54 CHINA KITS & REAGENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 124
TABLE 55 CHINA INSTRUMENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 124
TABLE 56 CHINA EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND) 124
TABLE 57 CHINA CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND) 125
TABLE 58 CHINA NON-CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND) 125
TABLE 59 CHINA EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 125
TABLE 60 CHINA THERAPEUTICS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 126
TABLE 61 CHINA DIAGNOSIS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 126
TABLE 62 CHINA EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 126
TABLE 63 CHINA PHARMACEUTICAL & BIOTECHNOLOGY COMPANY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 127
TABLE 64 CHINA RESEARCH CENTERS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 127
TABLE 65 CHINA ACADEMIC INSTITUTES IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 127
TABLE 66 CHINA CLINICAL TESTING LABORATORY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 127
TABLE 67 CHINA HOSPITALS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 128
TABLE 68 CHINA EXOSOME RESEARCH PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 128
TABLE 69 JAPAN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 129
TABLE 70 JAPAN CONSUMABLES IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 129
TABLE 71 JAPAN KITS & REAGENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 130
TABLE 72 JAPAN INSTRUMENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 130
TABLE 73 JAPAN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND) 130
TABLE 74 JAPAN CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND) 131
TABLE 75 JAPAN NON-CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND) 131
TABLE 76 JAPAN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 131
TABLE 77 JAPAN THERAPEUTICS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 132
TABLE 78 JAPAN DIAGNOSIS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 132
TABLE 79 JAPAN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 132
TABLE 80 JAPAN PHARMACEUTICAL & BIOTECHNOLOGY COMPANY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 133
TABLE 81 JAPAN RESEARCH CENTERS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 133
TABLE 82 JAPAN ACADEMIC INSTITUTES IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 133
TABLE 83 JAPAN CLINICAL TESTING LABORATORY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 133
TABLE 84 JAPAN HOSPITALS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 134
TABLE 85 JAPAN EXOSOME RESEARCH PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 134
TABLE 86 INDIA EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 135
TABLE 87 INDIA CONSUMABLES IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 135
TABLE 88 INDIA KITS & REAGENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 136
TABLE 89 INDIA INSTRUMENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 136
TABLE 90 INDIA EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND) 136
TABLE 91 INDIA CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND) 137
TABLE 92 INDIA NON-CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND) 137
TABLE 93 INDIA EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 137
TABLE 94 INDIA THERAPEUTICS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 138
TABLE 95 INDIA DIAGNOSIS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 138
TABLE 96 INDIA EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 138
TABLE 97 INDIA PHARMACEUTICAL & BIOTECHNOLOGY COMPANY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 139
TABLE 98 INDIA RESEARCH CENTERS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 139
TABLE 99 INDIA ACADEMIC INSTITUTES IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 139
TABLE 100 INDIA CLINICAL TESTING LABORATORY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 139
TABLE 101 INDIA HOSPITALS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 140
TABLE 102 INDIA EXOSOME RESEARCH PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 140
TABLE 103 SOUTH KOREA EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 141
TABLE 104 SOUTH KOREA CONSUMABLES IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 141
TABLE 105 SOUTH KOREA KITS & REAGENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 142
TABLE 106 SOUTH KOREA INSTRUMENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 142
TABLE 107 SOUTH KOREA EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND) 142
TABLE 108 SOUTH KOREA CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND) 143
TABLE 109 SOUTH KOREA NON-CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND) 143
TABLE 110 SOUTH KOREA EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 143
TABLE 111 SOUTH KOREA THERAPEUTICS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 144
TABLE 112 SOUTH KOREA DIAGNOSIS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 144
TABLE 113 SOUTH KOREA EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 144
TABLE 114 SOUTH KOREA PHARMACEUTICAL & BIOTECHNOLOGY COMPANY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 145
TABLE 115 SOUTH KOREA RESEARCH CENTERS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 145
TABLE 116 SOUTH KOREA ACADEMIC INSTITUTES IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 145
TABLE 117 SOUTH KOREA CLINICAL TESTING LABORATORY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 145
TABLE 118 SOUTH KOREA HOSPITALS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 146
TABLE 119 SOUTH KOREA EXOSOME RESEARCH PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 146
TABLE 120 AUSTRALIA EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 147
TABLE 121 AUSTRALIA CONSUMABLES IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 147
TABLE 122 AUSTRALIA KITS & REAGENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 148
TABLE 123 AUSTRALIA INSTRUMENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 148
TABLE 124 AUSTRALIA EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND) 148
TABLE 125 AUSTRALIA CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND) 149
TABLE 126 AUSTRALIA NON-CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND) 149
TABLE 127 AUSTRALIA EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 149
TABLE 128 AUSTRALIA THERAPEUTICS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 150
TABLE 129 AUSTRALIA DIAGNOSIS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 150
TABLE 130 AUSTRALIA EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 150
TABLE 131 AUSTRALIA PHARMACEUTICAL & BIOTECHNOLOGY COMPANY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 151
TABLE 132 AUSTRALIA RESEARCH CENTERS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 151
TABLE 133 AUSTRALIA ACADEMIC INSTITUTES IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 151
TABLE 134 AUSTRALIA CLINICAL TESTING LABORATORY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 151
TABLE 135 AUSTRALIA HOSPITALS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 152
TABLE 136 AUSTRALIA EXOSOME RESEARCH PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 152
TABLE 137 SINGAPORE EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 153
TABLE 138 SINGAPORE CONSUMABLES IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 153
TABLE 139 SINGAPORE KITS & REAGENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 154
TABLE 140 SINGAPORE INSTRUMENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 154
TABLE 141 SINGAPORE EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND) 154
TABLE 142 SINGAPORE CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND) 155
TABLE 143 SINGAPORE NON-CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND) 155
TABLE 144 SINGAPORE EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 155
TABLE 145 SINGAPORE THERAPEUTICS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 156
TABLE 146 SINGAPORE DIAGNOSIS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 156
TABLE 147 SINGAPORE EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 156
TABLE 148 SINGAPORE PHARMACEUTICAL & BIOTECHNOLOGY COMPANY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 157
TABLE 149 SINGAPORE RESEARCH CENTERS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 157
TABLE 150 SINGAPORE ACADEMIC INSTITUTES IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 157
TABLE 151 SINGAPORE CLINICAL TESTING LABORATORY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 157
TABLE 152 SINGAPORE HOSPITALS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 158
TABLE 153 SINGAPORE EXOSOME RESEARCH PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 158
TABLE 154 MALAYSIA EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 159
TABLE 155 MALAYSIA CONSUMABLES IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 159
TABLE 156 MALAYSIA KITS & REAGENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 160

LIST OF FIGURES

FIGURE 1 ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET: SEGMENTATION 31
FIGURE 2 ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET: DATA TRIANGULATION 34
FIGURE 3 ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET: DROC ANALYSIS 35
FIGURE 4 ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET: ASIA PACIFIC VS REGIONAL MARKET ANALYSIS 36
FIGURE 5 ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET: COMPANY RESEARCH ANALYSIS 36
FIGURE 6 ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET: INTERVIEW DEMOGRAPHICS 39
FIGURE 7 ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET: DBMR MARKET POSITION GRID 40
FIGURE 8 ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET: MARKET APPLICATION COVERAGE GRID 42
FIGURE 9 ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET: VENDOR SHARE ANALYSIS 43
FIGURE 10 ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET: SEGMENTATION 46
FIGURE 11 THE INCREASE IN THE PREVALENCE OF CANCER AND OTHER AUTO-IMMUNE DISEASE IS EXPECTED TO DRIVE THE ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET GROWTH IN THE FORECAST PERIOD 47
FIGURE 12 THE CONSUMABLES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET IN 2023 & 2030 47
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET 63
FIGURE 14 ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET: BY PRODUCT, 2022 71
FIGURE 15 ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET: BY PRODUCT, 2023-2030 (USD THOUSAND) 72
FIGURE 16 ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET: BY PRODUCT, CAGR (2023-2030) 72
FIGURE 17 ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET: BY PRODUCT, LIFELINE CURVE 73
FIGURE 18 ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET: BY INDICATION, 2022 80
FIGURE 19 ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET: BY INDICATION, 2023-2030 (USD THOUSAND) 81
FIGURE 20 ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET: BY INDICATION, CAGR (2023-2030) 81
FIGURE 21 ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET: BY INDICATION, LIFELINE CURVE 82
FIGURE 22 ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET: BY APPLICATION, 2022 88
FIGURE 23 ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET: BY APPLICATION, 2023-2030 (USD THOUSAND) 89
FIGURE 24 ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET: BY APPLICATION, CAGR (2023-2030) 89
FIGURE 25 ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET: BY APPLICATION, LIFELINE CURVE 90
FIGURE 26 ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET: BY END USER, 2022 95
FIGURE 27 ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET: BY END USER, 2023-2030 (USD THOUSAND) 96
FIGURE 28 ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET: BY END USER, CAGR (2023-2030) 96
FIGURE 29 ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET: BY END USER, LIFELINE CURVE 97
FIGURE 30 ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET: BY DISTRIBUTION CHANNEL, 2022 106
FIGURE 31 ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD THOUSAND) 107
FIGURE 32 ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030) 107
FIGURE 33 ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET : BY DISTRIBUTION CHANNEL, LIFELINE CURVE 108
FIGURE 34 ASIA-PACIFIC EXOSOME RESEARCH PRODUCTS MARKET: SNAPSHOT (2022) 113
FIGURE 35 ASIA-PACIFIC EXOSOME RESEARCH PRODUCTS MARKET: BY COUNTRY (2022) 114
FIGURE 36 ASIA-PACIFIC EXOSOME RESEARCH PRODUCTS MARKET: BY COUNTRY (2023 & 2030) 114
FIGURE 37 ASIA-PACIFIC EXOSOME RESEARCH PRODUCTS MARKET: BY COUNTRY (2022 & 2030) 115
FIGURE 38 ASIA-PACIFIC EXOSOME RESEARCH PRODUCTS MARKET: PRODUCT (2023-2030) 115
FIGURE 39 ASIA PACIFIC EXOSOME RESEARCH PRODUCTS MARKET: COMPANY SHARE 2022 (%) 201